BURNABY, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon’s Chief Executive Officer, will present a corporate update at the 2019 Cantor Global Healthcare Conference in New York, NY on Wednesday, October 2, 2019 at 7:45 am ET.
A live audio webcast will be available on the investors section of Xenon’s website at www.xenon-pharma.com and will be posted for replay following the event.About Xenon Pharmaceuticals Inc.
Bay Street News